rtx-20210419
false000010182900001018292021-04-192021-04-190000101829us-gaap:CommonStockMember2021-04-192021-04-190000101829rtx:Notes2.150Due2030Member2021-04-192021-04-19
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________________
FORM 8-K
____________________________________
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 19, 2021
____________________________________
RAYTHEON TECHNOLOGIES CORPORATION
(Exact name of registrant as specified in its charter)
____________________________________ | | | | | | | | |
Delaware | 001-00812 | 06-0570975 |
(State of Incorporation) | (Commission File Number) | (IRS Employer Identification Number) |
| | | | | | | | | | | |
870 Winter Street, | Waltham, | Massachusetts | 02451 |
(Address of principal executive offices, including zip code) (Registrant's telephone number, including area code)
____________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below): | | | | | |
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Securities registered pursuant to Section 12(b) of the Act: | | | | | | | | | | | |
Title of each class | Trading Symbol(s) | | Name of each exchange on which registered |
Common Stock ($1 par value) | RTX | | New York Stock Exchange |
(CUSIP 75513E 101) | | | |
2.150% Notes due 2030 | RTX 30 | | New York Stock Exchange |
(CUSIP 75513E AB7) | | | |
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(d) Election of Director.
The Board of Directors of Raytheon Technologies Corporation (the “Company”) elected Bernard A. Harris, Jr. as an independent director effective April 19, 2021, with a term expiring at the 2022 Annual Meeting of Shareowners. The Board also appointed Dr. Harris to the Board’s Audit Committee and Special Activities Committee. A copy of the Company’s press release issued on April 19, 2021 regarding Dr. Harris’s election is filed as Exhibit 99.1 to this Form 8-K and is hereby incorporated herein by reference.
The election of Dr. Harris was not pursuant to any arrangement or understanding between Dr. Harris and any third party. As of the date of this report, neither Dr. Harris, nor any of his immediate family members, is a party, either directly or indirectly, to any transaction that is required to be reported pursuant to Item 404(a) of Regulation S-K.
Dr. Harris will be compensated consistent with the Company’s compensation programs for non-employee directors.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits. | | | | | |
Exhibit Number | Exhibit Description |
99.1 | |
| |
104 | Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. | | | | | | | | |
| RAYTHEON TECHNOLOGIES CORPORATION |
| (Registrant) |
| | |
Date: April 19, 2021 | By: | /S/ FRANK R. JIMENEZ |
| | Frank R. Jimenez |
| | Executive Vice President & General Counsel |
Document
| | | | | | | | |
| | |
| Raytheon Technologies |
| 870 Winter Street |
| Waltham, MA 02451 |
| USA |
| |
| Media Contact |
| | Michele Quintaglie |
| | C: 860.493.4364 |
| | michele.quintaglie@rtx.com |
| | |
| | Investor Contact |
| | Erin Somers |
| | C: 704.264.6854 |
| | erin.somers@rtx.com |
Raytheon Technologies Appoints Bernard A. Harris Jr. to Board of Directors
WALTHAM, Mass., April 19, 2021 – Raytheon Technologies (NYSE: RTX) today announced that its board of directors has elected Dr. Bernard A. Harris Jr. as a director. A distinguished former NASA astronaut who is currently the chief executive officer of Vesalius Ventures, a venture capital firm, Harris is an experienced business leader with significant accomplishments in space exploration and advancement of emerging technologies.
“We are honored to have Dr. Harris join our board,” said Raytheon Technologies chief executive officer Greg Hayes. “His groundbreaking work in space and his impressive leadership across business, education and healthcare are remarkable. We expect our management team, employees and shareowners will benefit from his extensive experience and from the leadership he demonstrates in community development.”
A veteran astronaut, Harris has logged more than 438 hours and traveled over 7.2 million miles in space. Selected into the Astronaut Corps in January 1990, he was a mission specialist on the space shuttle Columbia in 1993 and a payload commander on the space shuttle Discovery in 1995, becoming the first African American to walk in space. While at NASA, he conducted research in musculoskeletal physiology and clinical investigations of space adaptation, and he also developed in-flight medical devices to extend astronaut stays in space.
Harris is CEO and managing partner of Vesalius Ventures Inc., a venture capital firm that invests in early- to mid-stage healthcare technologies and companies. He is a member of the board of directors of U.S. Physical Therapy (Nasdaq: USPH) and Monebo Technologies. He serves as a trustee/director for Salient and Barings investment funds. In addition, he is on the boards of the National Academies of Science, Engineering and Medicine - Board on Health Policy, the Texas Medical Center, CHI St. Luke’s Health System, and the Harris Institute & Foundation.
Harris said, “I am truly honored by this opportunity. I am professionally and personally aligned to the very causes that are at the heart of Raytheon Technologies: space exploration, innovation, education and the importance of the corporation as a positive force in community development.”
Harris, who is 64 years old and lives in Houston, has extensive community and philanthropic experience. In 1998, he established the Harris Foundation, a nonprofit whose mission is to invest in community-based initiatives to support education, health and wealth. In addition, Harris is currently the chief executive officer of the National Math and Science Initiative, a nonprofit organization that supports STEM education.
He earned a Bachelor of Science in Biology from the University of Houston, a Master of Medical Science from the University of Texas Medical Branch at Galveston, a Master of Business Administration from the University of Houston - Clear Lake, and a Doctor of Medicine from Texas Tech University Health Sciences Center School of Medicine. He completed a residency in internal medicine at the Mayo Clinic, a National Research Council Fellowship in endocrinology at the NASA Ames Research Center and trained as a flight surgeon at the U.S. Air Force School of Aerospace Medicine. He is also a licensed private pilot and certified scuba diver.
Harris is the recipient of numerous awards, including seven honorary doctorates, the NASA Space Flight Medal and the NASA Award of Merit. He is a fellow of the American College of Physicians and was the recipient of the 2000 Horatio Alger Award.
About Raytheon Technologies
Raytheon Technologies Corporation is an aerospace and defense company that provides advanced systems and services for commercial, military and government customers worldwide. With four industry-leading businesses ― Collins Aerospace Systems, Pratt & Whitney, Raytheon Intelligence & Space, and Raytheon Missiles & Defense ― the company delivers solutions that push the boundaries in avionics, cybersecurity, directed energy, electric propulsion, hypersonics, and quantum physics. The company, formed in 2020 through the combination of Raytheon Company and the United Technologies Corporation aerospace businesses, is headquartered in Waltham, Massachusetts.
###